In the second approach, we investigated the major transcriptional difference in NAFLD by performing gene set enrichment analysis (GSEA), and then determining the relevance of Fgf21 in the NAFLD-related pathways. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.